Researchers have identified a protein that may help aggressive triple-negative breast cancer spread to the brain and survive once it gets there. The preclinical findings could point toward new ...

A new review argues that triple-negative breast cancer's heterogeneity and therapy resistance emerge from spatially organized ...

Deep inside every cell, the endoplasmic reticulum works as the cellular factory where newly made proteins are folded, checked ...

A deeper understanding of mitochondrial function could create new opportunities for treating triple-negative breast cancer ...

The FDA has approved two first-line indications for sacituzumab govitecan (Trodelvy, Gilead Sciences) for patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) ...

Systemic therapy de-escalation in early TNBC marks a shift in oncologic management, emphasizing the reduction of treatment intensity without compromising therapeutic efficacy. While the KEYNOTE-522 ...

Friends, have you heard of triple-negative breast cancer [TNBC]? It’s a particularly aggressive type of breast cancer that can grow and spread faster than other types of breast cancer and has a higher ...

COLD SPRING HARBOR, N.Y., June 30, 2025 /PRNewswire/ -- Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, it's also one of ...

TNBC is a type of invasive breast cancer that doesn’t have hormone receptors or HER2 proteins. Though treatment options for TNBC depend on several factors, they often include surgery, chemotherapy, ...

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new study led by Weill Cornell Medicine suggests a surprising way to stop it from ...